Procter & Gamble (PG) delivered mixed results in FY2026 on revenue of $48.4B versus the $46.6B estimate (+9.8% YoY) and EPS of $1.26. Below is the full Procter & Gamble earnings breakdown — the risk-adjusted verdict, price forecast, technicals, options and hedge-fund 13F holdings, decoded in plain English.
$48.4B (vs $46.6B est · +3.8% surprise · +9.8% YoY)
EPS
$1.26 (vs $1.24 est · +1.6% surprise · +5.5% YoY)
Share price
$239.33 (-2.0%)
Market cap
$2.31T
What you'll find
Next Procter & Gamble (PG) earnings date, the expected move and the estimates priced in
A clear Beat / Miss / In-line / Mixed verdict the moment Procter & Gamble reports
Revenue & EPS versus estimates, guidance and segment trends
Multi-lens price forecast — analyst, quant, technical and options views
Deep research: red flags, risk decoder and earnings-call sentiment
Technicals, options / implied volatility and unusual-activity signals
Hedge-fund and legendary-investor 13F holdings in Procter & Gamble (PG)
Side-by-side peer and historical earnings comparison
Frequently asked questions
When is Procter & Gamble's next earnings date?
Procter & Gamble's (PG) next scheduled earnings date is Jan 30, 2025. Magnisto shows the confirmed date, the options-implied expected move and the revenue and EPS estimates Wall Street is modeling into the report.
Did Procter & Gamble (PG) beat or miss earnings?
In FY2026, Procter & Gamble (PG) posted mixed results — revenue of $48.4B versus the $46.6B estimate (+3.8% surprise) and EPS of $1.26 versus $1.24 expected (+1.6% surprise). Magnisto decodes every Procter & Gamble (PG) report into a clear Beat, Miss, In-line or Mixed verdict and checks whether guidance was raised, held or cut.
What is the forecast for Procter & Gamble (PG) stock?
Magnisto blends analyst price targets, quantitative research, technical trend and options-implied moves into a scenario range for Procter & Gamble (PG), anchored to the current $239.33 share price, so you can weigh the bull, base and bear cases for Procter & Gamble side by side.
Is Procter & Gamble (PG) a buy right now?
Magnisto does not give buy or sell tips. It gives you the institutional-grade evidence — the verdict, valuation, risks, technicals and hedge-fund 13F flows — so you can decide whether Procter & Gamble fits your own thesis and risk profile. This is research, not investment advice.